These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 9461143

  • 21. Interleukin-1beta influences the effect of infliximab on temporomandibular joint pain in rheumatoid arthritis.
    Kopp S, Alstergren P, Ernestam S, Nordahl S, Bratt J.
    Scand J Rheumatol; 2006; 35(3):182-8. PubMed ID: 16766364
    [Abstract] [Full Text] [Related]

  • 22. Th1/Th17/Th22 immune response and their association with joint pain, imagenological bone loss, RANKL expression and osteoclast activity in temporomandibular joint osteoarthritis: A preliminary report.
    Monasterio G, Castillo F, Rojas L, Cafferata EA, Alvarez C, Carvajal P, Núñez C, Flores G, Díaz W, Vernal R.
    J Oral Rehabil; 2018 Aug; 45(8):589-597. PubMed ID: 29761933
    [Abstract] [Full Text] [Related]

  • 23. Determination of temporomandibular joint fluid concentrations using vitamin B12 as an internal standard.
    Alstergren P, Appelgren A, Appelgren B, Kopp S, Lundeberg T, Theodorsson E.
    Eur J Oral Sci; 1995 Aug; 103(4):214-8. PubMed ID: 7552951
    [Abstract] [Full Text] [Related]

  • 24. Tumor necrosis factor mediates temporomandibular joint bone tissue resorption in rheumatoid arthritis.
    Ahmed N, Petersson A, Catrina AI, Mustafa H, Alstergren P.
    Acta Odontol Scand; 2015 Apr; 73(3):232-40. PubMed ID: 25515682
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Tumor necrosis factor-alpha in synovial fluid and plasma from patients with chronic connective tissue disease and its relation to temporomandibular joint pain.
    Nordahl S, Alstergren P, Kopp S.
    J Oral Maxillofac Surg; 2000 May; 58(5):525-30. PubMed ID: 10800908
    [Abstract] [Full Text] [Related]

  • 27. Cytokines in temporomandibular joint synovial fluid and tissue in relation to inflammation.
    Ulmner M, Sugars R, Naimi-Akbar A, Alstergren P, Lund B.
    J Oral Rehabil; 2022 Jun; 49(6):599-607. PubMed ID: 35342975
    [Abstract] [Full Text] [Related]

  • 28. Temporomandibular joint pain: relationship to internal derangement type, osteoarthrosis, and synovial fluid mediator level of tumor necrosis factor-alpha.
    Emshoff R, Puffer P, Rudisch A, Gassner R.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2000 Oct; 90(4):442-9. PubMed ID: 11027380
    [Abstract] [Full Text] [Related]

  • 29. Postnatal development of substance P-, calcitonin gene-related peptide- and neuropeptide Y-like immunoreactive nerve fibres in the synovial membrane of the rat temporomandibular joint.
    Shimizu S, Kido MA, Kiyoshima T, Tanaka T.
    Arch Oral Biol; 1996 Oct; 41(8-9):749-59. PubMed ID: 9022912
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. 5-HT induces temporomandibular joint nociception in rats through the local release of inflammatory mediators and activation of local β adrenoceptors.
    Oliveira-Fusaro MC, Clemente-Napimoga JT, Teixeira JM, Torres-Chávez KE, Parada CA, Tambeli CH.
    Pharmacol Biochem Behav; 2012 Sep; 102(3):458-64. PubMed ID: 22683622
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Effects of glucosamine-chondroitin combination on synovial fluid IL-1β, IL-6, TNF-α and PGE2 levels in internal derangements of temporomandibular joint.
    Damlar I, Esen E, Tatli U.
    Med Oral Patol Oral Cir Bucal; 2015 May 01; 20(3):e278-83. PubMed ID: 25662545
    [Abstract] [Full Text] [Related]

  • 37. Topical review: new insights into the pathology and diagnosis of disorders of the temporomandibular joint.
    Lobbezoo F, Drangsholt M, Peck C, Sato H, Kopp S, Svensson P.
    J Orofac Pain; 2004 May 01; 18(3):181-91. PubMed ID: 15508997
    [Abstract] [Full Text] [Related]

  • 38. Determination of interleukin-1 receptor antagonist, interleukin-10, and transforming growth factor-beta1 in synovial fluid aspirates of patients with temporomandibular disorders.
    Fang PK, Ma XC, Ma DL, Fu KY.
    J Oral Maxillofac Surg; 1999 Aug 01; 57(8):922-8; discussion 928-9. PubMed ID: 10437719
    [Abstract] [Full Text] [Related]

  • 39. Interleukin 1 beta and stromelysin (MMP3) activity of synovial fluid as possible markers of osteoarthritis in the temporomandibular joint.
    Kubota E, Imamura H, Kubota T, Shibata T, Murakami K.
    J Oral Maxillofac Surg; 1997 Jan 01; 55(1):20-7; discussion 27-8. PubMed ID: 8994464
    [Abstract] [Full Text] [Related]

  • 40. The role of molecular pain biomarkers in temporomandibular joint internal derangement.
    Ernberg M.
    J Oral Rehabil; 2017 Jun 01; 44(6):481-491. PubMed ID: 28054366
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.